001     139622
005     20250415125852.0
024 7 _ |a 10.1007/s00391-017-1225-3
|2 doi
024 7 _ |a pmid:28405748
|2 pmid
024 7 _ |a 0044-281X
|2 ISSN
024 7 _ |a 0948-6704
|2 ISSN
024 7 _ |a 1435-1269
|2 ISSN
037 _ _ |a DZNE-2020-05944
041 _ _ |a English
082 _ _ |a 150
100 1 _ |a Kilimann, Ingo
|0 P:(DE-2719)2810394
|b 0
|e First author
|u dzne
245 _ _ |a Translation of imaging biomarkers from clinical research to healthcare.
260 _ _ |a Heidelberg
|c 2017
|b Springer Medizin
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2017-04-12
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2017-05-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1744714694_17922
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The use of biomarkers for diagnostics of Alzheimer's disease (AD) has increased over the last years in specialized care and experimental settings. With the possibly upcoming availability of disease-modifying therapeutic agents, the diagnostics and treatment of patients with cognitive impairment will change. Biomarkers will be used as theranostic markers for case finding. The development and evaluation of biomarkers can be framed in a phase model from preclinical studies through trials in expert center settings to the evaluation of biomarkers in primary care, up to testing the efficacy and the impact of biomarkers on the healthcare system. Hippocampal volumetry is the most accepted and in-depth tested biomarker for AD diagnostics and prediction of the course. Therefore, hippocampus volumetry is used to illustrate the phase model of biomarker development and present the milestones already achieved and questions still to be resolved.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2017-04-12
|2 Crossref
|u http://www.springer.com/tdm
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Biomarkers
|2 NLM Chemicals
650 _ 2 |a Alzheimer Disease: diagnostic imaging
|2 MeSH
650 _ 2 |a Alzheimer Disease: metabolism
|2 MeSH
650 _ 2 |a Alzheimer Disease: pathology
|2 MeSH
650 _ 2 |a Biomarkers: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Brain: diagnostic imaging
|2 MeSH
650 _ 2 |a Brain: metabolism
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
650 _ 2 |a Health Services Research: organization & administration
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Molecular Imaging: methods
|2 MeSH
650 _ 2 |a Positron-Emission Tomography: methods
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a Sensitivity and Specificity
|2 MeSH
650 _ 2 |a Translational Medical Research: organization & administration
|2 MeSH
700 1 _ |a Thyrian, Jochen René
|0 P:(DE-2719)2290613
|b 1
|u dzne
700 1 _ |a Hoffmann, Wolfgang
|0 P:(DE-2719)2000040
|b 2
|u dzne
700 1 _ |a Teipel, Stefan J
|0 P:(DE-2719)2000026
|b 3
|e Last author
|u dzne
773 1 8 |a 10.1007/s00391-017-1225-3
|b : Springer Science and Business Media LLC, 2017-04-12
|n S2
|p 84-88
|3 journal-article
|2 Crossref
|t Zeitschrift für Gerontologie und Geriatrie
|v 50
|y 2017
|x 0948-6704
773 _ _ |a 10.1007/s00391-017-1225-3
|g Vol. 50, no. Suppl 2, p. 84 - 88
|0 PERI:(DE-600)1463317-6
|n S2
|q 50:Suppl 2<84 - 88
|p 84-88
|t Zeitschrift für Gerontologie und Geriatrie
|v 50
|y 2017
|x 0948-6704
856 4 _ |u https://pub.dzne.de/record/139622/files/DZNE-2020-05944_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/139622/files/DZNE-2020-05944_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:139622
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810394
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2290613
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2000040
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2000026
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2017
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2022-11-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b Z GERONTOL GERIATR : 2021
|d 2022-11-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-22
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research (Rostock /Greifswald)
|x 0
920 1 _ |0 I:(DE-2719)1510800
|k AG Thyrian
|l Interventional Health Care Research (IHCR)
|x 1
920 1 _ |0 I:(DE-2719)1510600
|k AG Hoffmann
|l Translational Health Care Research
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a I:(DE-2719)1510800
980 _ _ |a I:(DE-2719)1510600
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2011.03.008
|2 Crossref
|o 10.1016/j.jalz.2011.03.008
999 C 5 |9 -- missing cx lookup --
|a 10.1067/mcp.2001.113989
|2 Crossref
|o 10.1067/mcp.2001.113989
999 C 5 |9 -- missing cx lookup --
|a 10.1007/BF00692056
|2 Crossref
|o 10.1007/BF00692056
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0306-4522(99)00476-5
|2 Crossref
|o 10.1016/S0306-4522(99)00476-5
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2011-0004
|2 Crossref
|o 10.3233/JAD-2011-0004
999 C 5 |9 -- missing cx lookup --
|a 10.1007/BF00308809
|2 Crossref
|o 10.1007/BF00308809
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-150063
|2 Crossref
|o 10.3233/JAD-150063
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2013.02.002
|2 Crossref
|o 10.1016/j.neurobiolaging.2013.02.002
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0140-6736(89)90911-2
|2 Crossref
|o 10.1016/S0140-6736(89)90911-2
999 C 5 |y 1993
|2 Crossref
|o MJ Leon De 1993
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2014.05.1756
|2 Crossref
|o 10.1016/j.jalz.2014.05.1756
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-010-5650-0
|2 Crossref
|o 10.1007/s00415-010-5650-0
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.58.10.1476
|2 Crossref
|o 10.1212/WNL.58.10.1476
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.pneurobio.2011.11.008
|2 Crossref
|o 10.1016/j.pneurobio.2011.11.008
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.58.5.750
|2 Crossref
|o 10.1212/WNL.58.5.750
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.41.1.51
|2 Crossref
|o 10.1212/WNL.41.1.51
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2011.03.005
|2 Crossref
|o 10.1016/j.jalz.2011.03.005
999 C 5 |9 -- missing cx lookup --
|a 10.1080/14728214.2016.1241232
|2 Crossref
|o 10.1080/14728214.2016.1241232
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1541-0420.2005.00420.x
|2 Crossref
|o 10.1111/j.1541-0420.2005.00420.x
999 C 5 |9 -- missing cx lookup --
|a 10.1093/jnci/93.14.1054
|2 Crossref
|o 10.1093/jnci/93.14.1054
999 C 5 |9 -- missing cx lookup --
|a 10.2174/156720509788929273
|2 Crossref
|o 10.2174/156720509788929273
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awp007
|2 Crossref
|o 10.1093/brain/awp007
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(15)00093-9
|2 Crossref
|o 10.1016/S1474-4422(15)00093-9
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-160778
|2 Crossref
|o 10.3233/JAD-160778
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1745-6215-13-56
|2 Crossref
|o 10.1186/1745-6215-13-56
999 C 5 |9 -- missing cx lookup --
|a 10.1002/gps.4126
|2 Crossref
|o 10.1002/gps.4126
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2017.01.009
|2 Crossref
|o 10.1016/j.jalz.2017.01.009


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21